These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3061941)

  • 1. Comparative study of the abuse liability of alprazolam, lorazepam, diazepam, methaqualone, and placebo.
    Orzack MH; Friedman L; Dessain E; Bird M; Beake B; McEachern J; Cole JO
    Int J Addict; 1988 May; 23(5):449-67. PubMed ID: 3061941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the abuse liability of buspirone in recreational sedative users.
    Cole JO; Orzack MH; Beake B; Bird M; Bar-Tal Y
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):69-75. PubMed ID: 6130076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential for abuse of alprazolam.
    Cole JO; Orzack MH
    Am J Psychiatry; 1988 Dec; 145(12):1609-10. PubMed ID: 3057926
    [No Abstract]   [Full Text] [Related]  

  • 4. Methaqualone.
    Ionescu-Pioggia M; Bird M; Orzack MH; Benes F; Beake B; Cole JO
    Int Clin Psychopharmacol; 1988 Apr; 3(2):97-109. PubMed ID: 3397524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic effects and abuse liability of bretazenil, diazepam, and alprazolam in humans.
    Busto U; Kaplan HL; Zawertailo L; Sellers EM
    Clin Pharmacol Ther; 1994 Apr; 55(4):451-63. PubMed ID: 8162672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The benzodiazepines as drugs of abuse.
    Cole JO; Chiarello RJ
    J Psychiatr Res; 1990; 24 Suppl 2():135-44. PubMed ID: 1980692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative abuse liability of lorazepam and diazepam: an evaluation in 'recreational' drug users.
    Funderburk FR; Griffiths RR; McLeod DR; Bigelow GE; Mackenzie A; Liebson IA; Nemeth-Coslett R
    Drug Alcohol Depend; 1988 Dec; 22(3):215-22. PubMed ID: 3234245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative abuse liability of sertraline, alprazolam, and dextroamphetamine in humans.
    Zawertailo LA; Busto U; Kaplan HL; Sellers EM
    J Clin Psychopharmacol; 1995 Apr; 15(2):117-24. PubMed ID: 7782484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative abuse liability of different benzodiazepines in drug abusers.
    Griffiths RR; Wolf B
    J Clin Psychopharmacol; 1990 Aug; 10(4):237-43. PubMed ID: 1981067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Behavioral and electroencephalographic effects of alprazolam and its metabolites (author's transl)].
    Ueki S; Watanabe S; Yamamoto T; Kataoka Y; Tazoe N; Shibata S; Shibata K; Ohta H; Kawahara K; Takano M; Suwandi D; Lee SC; Liou SY
    Nihon Yakurigaku Zasshi; 1981 May; 77(5):483-509. PubMed ID: 7197658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of the side-effect profile of buspirone.
    Newton RE; Marunycz JD; Alderdice MT; Napoliello MJ
    Am J Med; 1986 Mar; 80(3B):17-21. PubMed ID: 2870641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abuse liability of alprazolam relative to other commonly used benzodiazepines: a review.
    Rush CR; Higgins ST; Bickel WK; Hughes JR
    Neurosci Biobehav Rev; 1993; 17(3):277-85. PubMed ID: 7903805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abuse liability assessment of eslicarbazepine acetate in healthy male and female recreational sedative users: A Phase I randomized controlled trial.
    Levy-Cooperman N; Schoedel KA; Chakraborty B; Blum D; Cheng H
    Epilepsy Behav; 2016 Aug; 61():63-71. PubMed ID: 27315134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacokinetics and pharmacodynamics of lorazepam, alprazolam and diazepam.
    Ellinwood EH; Heatherly DG; Nikaido AM; Bjornsson TD; Kilts C
    Psychopharmacology (Berl); 1985; 86(4):392-9. PubMed ID: 2863843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propranolol interactions with diazepam, lorazepam, and alprazolam.
    Ochs HR; Greenblatt DJ; Verburg-Ochs B
    Clin Pharmacol Ther; 1984 Oct; 36(4):451-5. PubMed ID: 6434219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the abuse liability of buspirone in alcohol-dependent patients.
    Griffith JD; Jasinski DR; Casten GP; McKinney GR
    Am J Med; 1986 Mar; 80(3B):30-5. PubMed ID: 3963032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of acute alprazolam (0.25, 0.50 and 1.0 mg) effects versus those of lorazepam 2 mg and placebo on memory in healthy volunteers using laboratory and telephone tests.
    Vermeeren A; Jackson JL; Muntjewerff ND; Quint PJ; Harrison EM; O'Hanlon JF
    Psychopharmacology (Berl); 1995 Mar; 118(1):1-9. PubMed ID: 7597114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in pharmacodynamics of anxiolytics in abstinent alcoholic men: subjective responses, abuse liability, and electroencephalographic effects of alprazolam, diazepam, and buspirone.
    Ciraulo DA; Barnhill JG; Ciraulo AM; Sarid-Segal O; Knapp C; Greenblatt DJ; Shader RI
    J Clin Pharmacol; 1997 Jan; 37(1):64-73. PubMed ID: 9048275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of fractures requiring hospitalization after an initial prescription for zolpidem, alprazolam, lorazepam, or diazepam in older adults.
    Finkle WD; Der JS; Greenland S; Adams JL; Ridgeway G; Blaschke T; Wang Z; Dell RM; VanRiper KB
    J Am Geriatr Soc; 2011 Oct; 59(10):1883-90. PubMed ID: 22091502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial.
    Schoedel KA; Szeto I; Setnik B; Sellers EM; Levy-Cooperman N; Mills C; Etges T; Sommerville K
    Epilepsy Behav; 2018 Nov; 88():162-171. PubMed ID: 30286443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.